Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharmacol Exp Ther ; 316(2): 628-35, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16227472

ABSTRACT

Phytoestrogens are naturally occurring estrogenic compounds found in plants and plant products. These compounds are also known to exert cellular effects independent of their interactions with estrogen receptors. We studied the effects of the phytoestrogens phloretin, phloridzin, genistein, and biochanin A on Ca(2+) uptake into the cardiac muscle sarcoplasmic reticulum (SR). Genistein and biochanin A did not affect SR Ca(2+) uptake. On the other hand, phloretin and phloridzin decreased the maximum velocity of SR Ca(2+) uptake but did not affect the Hill coefficient or the Ca(2+) sensitivity of uptake. Measurements of the ATPase activity of the cardiac SR Ca(2+) pump (SERCA2a) revealed direct inhibitory effects of phloretin and phloridzin on SERCA2a. Neither compound induced a detectable change in the permeability of the SR membrane to Ca(2+). These results indicate that phloretin and phloridzin inhibit cardiac SR Ca(2+) uptake by directly inhibiting SERCA2a.


Subject(s)
Calcium-Transporting ATPases/metabolism , Calcium/metabolism , Heart/drug effects , Myocardium , Phytoestrogens/pharmacology , Sarcoplasmic Reticulum/drug effects , Animals , Dogs , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/enzymology , Endoplasmic Reticulum/metabolism , Heart Ventricles/drug effects , Heart Ventricles/enzymology , Heart Ventricles/metabolism , In Vitro Techniques , Intracellular Membranes/drug effects , Intracellular Membranes/enzymology , Intracellular Membranes/metabolism , Myocardium/enzymology , Myocardium/metabolism , Sarcoplasmic Reticulum/enzymology , Sarcoplasmic Reticulum/metabolism
2.
Kidney Int ; 66(5): 1890-900, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15496160

ABSTRACT

BACKGROUND: In cultured renal epithelial cells, exposure to oxalate, a constituent of many kidney stones, elicits a cascade of responses that often leads to cell death. Oxalate toxicity is mediated via generation of reactive oxygen species (ROS) in a process that depends at least in part upon lipid signaling molecules that are generated through membrane events that culminate in phospholipase A2 (PLA2) activation. The present studies asked whether mitochondria, a major site of ROS production, were targets of oxalate toxicity, and if so, whether mitochondrial responses to oxalate were mediated by PLA2 activation. METHODS: Effects of oxalate and various lipids on mitochondrial membrane potential (DeltaPsim) were measured in Madin-Darby canine kidney (MDCK) cell monolayers using 5,5',6,6'-tetrachloro 1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), a DeltaPsim-sensitive dye. Other studies assayed caspases, serine proteases activated during apoptosis, in response to oxalate or lipid signaling molecules. Additional studies asked whether oxalate or lipids produced by PLA2 activation promoted ROS formation in isolated renal mitochondria. RESULTS: Oxalate exposure decreased MDCK cell DeltaPsim within 30 minutes, a response attenuated by arachidonyl trifluoromethyl ketone (AACOCF3), an inhibitor of cytosolic PLA2 (cPLA2). Exposure to arachidonic acid or to lysophosphatidylcholine (lyso-PC), lipid products of PLA2 activation, or to ceramide, another lipid signal generated in MDCK cells following oxalate exposure, also depolarized MDCK cell DeltaPsim and increased the number of caspase-positive cells. Isolated renal mitochondria responded to oxalate, arachidonic acid, lyso-PC, and ceramide by increasing their accumulation of ROS, lipid peroxides, and oxidized thiol proteins. CONCLUSION: These studies suggest that lipid signaling molecules released after oxalate-induced PLA2 activation trigger marked, rapid changes in mitochondrial function that may mediate toxicity in renal epithelial cells.


Subject(s)
Kidney/drug effects , Kidney/physiopathology , Mitochondria/drug effects , Oxalates/poisoning , Sphingosine/analogs & derivatives , Animals , Arachidonic Acid/pharmacology , Arachidonic Acids/pharmacology , Caspases/metabolism , Cell Line , Dogs , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Intracellular Membranes/drug effects , Kidney/metabolism , Lipid Peroxidation/drug effects , Lysophosphatidylcholines/pharmacology , Membrane Potentials/drug effects , Mitochondria/metabolism , Phospholipases A/antagonists & inhibitors , Phospholipases A2 , Reactive Oxygen Species/metabolism , Sphingosine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...